nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—CA6—ear—leprosy	0.109	0.152	CbGeAlD
Acetazolamide—CA3—ear—leprosy	0.103	0.144	CbGeAlD
Acetazolamide—AQP1—blood vessel—leprosy	0.0695	0.0967	CbGeAlD
Acetazolamide—AQP1—eye—leprosy	0.037	0.0515	CbGeAlD
Acetazolamide—CA1—nerve—leprosy	0.0364	0.0507	CbGeAlD
Acetazolamide—AQP1—skin of body—leprosy	0.0322	0.0448	CbGeAlD
Acetazolamide—CA4—nerve—leprosy	0.0284	0.0396	CbGeAlD
Acetazolamide—AQP1—tendon—leprosy	0.0245	0.0341	CbGeAlD
Acetazolamide—Electrolyte imbalance—Thalidomide—leprosy	0.0228	0.0809	CcSEcCtD
Acetazolamide—AQP1—testis—leprosy	0.0203	0.0282	CbGeAlD
Acetazolamide—AQP1—nervous system—leprosy	0.0199	0.0277	CbGeAlD
Acetazolamide—CA12—eye—leprosy	0.0192	0.0267	CbGeAlD
Acetazolamide—CA3—tendon—leprosy	0.018	0.025	CbGeAlD
Acetazolamide—CA9—tendon—leprosy	0.0172	0.0239	CbGeAlD
Acetazolamide—CA14—tendon—leprosy	0.0163	0.0227	CbGeAlD
Acetazolamide—CA1—eye—leprosy	0.0152	0.0212	CbGeAlD
Acetazolamide—CA3—testis—leprosy	0.0149	0.0207	CbGeAlD
Acetazolamide—CA3—nervous system—leprosy	0.0146	0.0203	CbGeAlD
Acetazolamide—CA9—testis—leprosy	0.0142	0.0198	CbGeAlD
Acetazolamide—Tingling sensation—Thalidomide—leprosy	0.0118	0.042	CcSEcCtD
Acetazolamide—Numbness—Thalidomide—leprosy	0.0115	0.0408	CcSEcCtD
Acetazolamide—CA5B—tendon—leprosy	0.0114	0.0159	CbGeAlD
Acetazolamide—Blood disorder—Thalidomide—leprosy	0.0114	0.0405	CcSEcCtD
Acetazolamide—Sensory loss—Thalidomide—leprosy	0.011	0.039	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Thalidomide—leprosy	0.0108	0.0385	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Dapsone—leprosy	0.0107	0.0378	CcSEcCtD
Acetazolamide—CA12—nervous system—leprosy	0.0103	0.0144	CbGeAlD
Acetazolamide—CA2—eye—leprosy	0.00986	0.0137	CbGeAlD
Acetazolamide—CA5B—testis—leprosy	0.00944	0.0132	CbGeAlD
Acetazolamide—CA5B—nervous system—leprosy	0.00927	0.0129	CbGeAlD
Acetazolamide—Aplastic anaemia—Thalidomide—leprosy	0.00894	0.0317	CcSEcCtD
Acetazolamide—Tinnitus—Dapsone—leprosy	0.00871	0.0309	CcSEcCtD
Acetazolamide—CA2—skin of body—leprosy	0.00858	0.0119	CbGeAlD
Acetazolamide—CA1—nervous system—leprosy	0.00819	0.0114	CbGeAlD
Acetazolamide—Photosensitivity—Thalidomide—leprosy	0.00787	0.0279	CcSEcCtD
Acetazolamide—CA4—tendon—leprosy	0.00787	0.011	CbGeAlD
Acetazolamide—Hypoglycaemia—Thalidomide—leprosy	0.00708	0.0251	CcSEcCtD
Acetazolamide—Hyponatraemia—Thalidomide—leprosy	0.00694	0.0246	CcSEcCtD
Acetazolamide—CA2—tendon—leprosy	0.00653	0.00909	CbGeAlD
Acetazolamide—CA4—testis—leprosy	0.00652	0.00908	CbGeAlD
Acetazolamide—Ataxia—Thalidomide—leprosy	0.0065	0.0231	CcSEcCtD
Acetazolamide—CA4—nervous system—leprosy	0.0064	0.00891	CbGeAlD
Acetazolamide—Hypokalaemia—Thalidomide—leprosy	0.00629	0.0223	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00623	0.0221	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Thalidomide—leprosy	0.00545	0.0194	CcSEcCtD
Acetazolamide—CA2—testis—leprosy	0.00541	0.00753	CbGeAlD
Acetazolamide—Drowsiness—Thalidomide—leprosy	0.00533	0.0189	CcSEcCtD
Acetazolamide—CA2—nervous system—leprosy	0.00531	0.00739	CbGeAlD
Acetazolamide—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00528	0.0187	CcSEcCtD
Acetazolamide—Body temperature increased—Dapsone—leprosy	0.00525	0.0186	CcSEcCtD
Acetazolamide—Haematuria—Thalidomide—leprosy	0.00508	0.018	CcSEcCtD
Acetazolamide—Agranulocytosis—Thalidomide—leprosy	0.00497	0.0176	CcSEcCtD
Acetazolamide—Hypoaesthesia—Thalidomide—leprosy	0.00476	0.0169	CcSEcCtD
Acetazolamide—Erythema multiforme—Thalidomide—leprosy	0.00452	0.016	CcSEcCtD
Acetazolamide—Tinnitus—Thalidomide—leprosy	0.00446	0.0158	CcSEcCtD
Acetazolamide—Vomiting—Dapsone—leprosy	0.00422	0.015	CcSEcCtD
Acetazolamide—Headache—Dapsone—leprosy	0.00416	0.0148	CcSEcCtD
Acetazolamide—Dysgeusia—Thalidomide—leprosy	0.00408	0.0145	CcSEcCtD
Acetazolamide—Nausea—Dapsone—leprosy	0.00394	0.014	CcSEcCtD
Acetazolamide—Ill-defined disorder—Thalidomide—leprosy	0.00386	0.0137	CcSEcCtD
Acetazolamide—Agitation—Thalidomide—leprosy	0.00383	0.0136	CcSEcCtD
Acetazolamide—Malaise—Thalidomide—leprosy	0.00375	0.0133	CcSEcCtD
Acetazolamide—Leukopenia—Thalidomide—leprosy	0.00373	0.0132	CcSEcCtD
Acetazolamide—Convulsion—Thalidomide—leprosy	0.00361	0.0128	CcSEcCtD
Acetazolamide—Discomfort—Thalidomide—leprosy	0.0035	0.0124	CcSEcCtD
Acetazolamide—Confusional state—Thalidomide—leprosy	0.00343	0.0122	CcSEcCtD
Acetazolamide—CYP3A4—nervous system—leprosy	0.00342	0.00477	CbGeAlD
Acetazolamide—Shock—Thalidomide—leprosy	0.00334	0.0119	CcSEcCtD
Acetazolamide—Thrombocytopenia—Thalidomide—leprosy	0.00333	0.0118	CcSEcCtD
Acetazolamide—Paraesthesia—Thalidomide—leprosy	0.00305	0.0108	CcSEcCtD
Acetazolamide—Somnolence—Thalidomide—leprosy	0.00302	0.0107	CcSEcCtD
Acetazolamide—Dyspepsia—Thalidomide—leprosy	0.00299	0.0106	CcSEcCtD
Acetazolamide—Decreased appetite—Thalidomide—leprosy	0.00295	0.0105	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Thalidomide—leprosy	0.00293	0.0104	CcSEcCtD
Acetazolamide—Fatigue—Thalidomide—leprosy	0.00293	0.0104	CcSEcCtD
Acetazolamide—Feeling abnormal—Thalidomide—leprosy	0.0028	0.00994	CcSEcCtD
Acetazolamide—Urticaria—Thalidomide—leprosy	0.0027	0.00958	CcSEcCtD
Acetazolamide—Body temperature increased—Thalidomide—leprosy	0.00269	0.00953	CcSEcCtD
Acetazolamide—Asthenia—Thalidomide—leprosy	0.00244	0.00865	CcSEcCtD
Acetazolamide—Diarrhoea—Thalidomide—leprosy	0.00233	0.00825	CcSEcCtD
Acetazolamide—Dizziness—Thalidomide—leprosy	0.00225	0.00797	CcSEcCtD
Acetazolamide—Vomiting—Thalidomide—leprosy	0.00216	0.00767	CcSEcCtD
Acetazolamide—Headache—Thalidomide—leprosy	0.00213	0.00755	CcSEcCtD
Acetazolamide—Nausea—Thalidomide—leprosy	0.00202	0.00716	CcSEcCtD
